Dynova Laboratories Inc
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Apr 2007 | $15 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Dynova Laboratories Inc had revenue between $1 million and $5 million when it filed its newest notice of a funding round (Dec 2009).
SEC Form D (revenue range) · Dec 2009
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2009
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Dynova Laboratories Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 2 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew Schiff, MD | Executive officer | Dec 2009 |
| Anthony Y. Sun, MD | Executive officer | Dec 2009 |
| Dennis Y. Purcell | Executive officer | Dec 2009 |
| Lynne Y. Millheiser Swanbeck | Executive officer | Dec 2009 |
| Dennis Purcell | Executive officer | Jun 2009 |
| Lynne Millheiser Swanbeck | Executive officer | Jun 2009 |
| Andrew Schiff, MD | Director | Dec 2009 |
| Anthony Y. Sun, MD | Director | Dec 2009 |
| Dennis Y. Purcell | Director | Dec 2009 |
| Lynne Y. Millheiser Swanbeck | Director | Dec 2009 |
| Dennis Purcell | Director | Jun 2009 |
| Lynne Millheiser Swanbeck | Director | Jun 2009 |
| N/A Aisling Capital | Promoter | Dec 2009 |
| N/A Menemsha Capital Partners | Promoter | Dec 2009 |